HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,000 | – | 11,333 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 72,452 | $44,000 | 0.00% |
| HighMark Wealth Management LLC | 6,966 | $4,000 | 0.00% |
| UBS Group AG | 26 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 46 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 47,178 | $28,000 | 0.00% |
| STATE STREET CORP | 14,455 | $9,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 23,683 | $15,000 | 0.00% |
| MORGAN STANLEY | 10,611 | $7,000 | 0.00% |
| BlackRock Inc. | 74,192 | $45,000 | 0.00% |